ID   GDPD2_HUMAN             Reviewed;         539 AA.
AC   Q9HCC8; B4DRH4; B4DVC9; Q9NXJ6;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   18-JUN-2025, entry version 174.
DE   RecName: Full=Glycerophosphoinositol inositolphosphodiesterase GDPD2;
DE            EC=3.1.4.43;
DE   AltName: Full=Glycerophosphodiester phosphodiesterase 3;
DE   AltName: Full=Glycerophosphodiester phosphodiesterase domain-containing protein 2;
DE   AltName: Full=Osteoblast differentiation promoting factor;
GN   Name=GDPD2; Synonyms=GDE3, OBDPF; ORFNames=UNQ1935/PRO4418;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Spleen;
RX   PubMed=12933806; DOI=10.1074/jbc.m302867200;
RA   Yanaka N., Imai Y., Kawai E., Akatsuka H., Wakimoto K., Nogusa Y., Kato N.,
RA   Chiba H., Kotani E., Omori K., Sakurai N.;
RT   "Novel membrane protein containing glycerophosphodiester phosphodiesterase
RT   motif is transiently expressed during osteoblast differentiation.";
RL   J. Biol. Chem. 278:43595-43602(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Caudate nucleus, Colon mucosa, and Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Has glycerophosphoinositol inositolphosphodiesterase activity
CC       and specifically hydrolyzes glycerophosphoinositol, with no activity
CC       for other substrates such as glycerophosphoinositol 4-phosphate,
CC       glycerophosphocholine, glycerophosphoethanolamine, and
CC       glycerophosphoserine. Accelerates the program of osteoblast
CC       differentiation and growth. May play a role in remodeling of the actin
CC       cytoskeleton (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=sn-glycero-3-phospho-1D-myo-inositol + H2O = 1D-myo-inositol
CC         1-phosphate + glycerol + H(+); Xref=Rhea:RHEA:14033,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17754,
CC         ChEBI:CHEBI:58433, ChEBI:CHEBI:58444; EC=3.1.4.43;
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cytoplasm. Cytoplasm, cytoskeleton {ECO:0000250}. Note=Colocalizes with
CC       the actin cytoskeleton. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9HCC8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HCC8-2; Sequence=VSP_042622;
CC       Name=3;
CC         IsoId=Q9HCC8-3; Sequence=VSP_042623;
CC   -!- SIMILARITY: Belongs to the glycerophosphoryl diester phosphodiesterase
CC       family. {ECO:0000305}.
CC   -!- CAUTION: The catalytic domain of GDPD2 is oriented extracellularly;
CC       Glycerophosphoinositol is hydrolyzed in the medium of cells
CC       overexpressing Gdpd2, whereas intracellular levels of
CC       glycerophosphoinositol is not affected. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91014.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB048363; BAB13350.1; -; mRNA.
DR   EMBL; AY358986; AAQ89345.1; -; mRNA.
DR   EMBL; AK000214; BAA91014.1; ALT_FRAME; mRNA.
DR   EMBL; AK299255; BAG61286.1; -; mRNA.
DR   EMBL; AK301025; BAG62641.1; -; mRNA.
DR   EMBL; AK316035; BAH14406.1; -; mRNA.
DR   EMBL; AL139398; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032009; AAH32009.1; -; mRNA.
DR   CCDS; CCDS14402.1; -. [Q9HCC8-1]
DR   CCDS; CCDS55437.1; -. [Q9HCC8-3]
DR   CCDS; CCDS55438.1; -. [Q9HCC8-2]
DR   RefSeq; NP_001164662.1; NM_001171191.2. [Q9HCC8-2]
DR   RefSeq; NP_001164663.1; NM_001171192.2. [Q9HCC8-3]
DR   RefSeq; NP_001164664.1; NM_001171193.2. [Q9HCC8-2]
DR   RefSeq; NP_060181.2; NM_017711.3. [Q9HCC8-1]
DR   AlphaFoldDB; Q9HCC8; -.
DR   SMR; Q9HCC8; -.
DR   BioGRID; 120207; 5.
DR   FunCoup; Q9HCC8; 390.
DR   IntAct; Q9HCC8; 43.
DR   MINT; Q9HCC8; -.
DR   STRING; 9606.ENSP00000414019; -.
DR   GlyCosmos; Q9HCC8; 1 site, No reported glycans.
DR   GlyGen; Q9HCC8; 1 site.
DR   iPTMnet; Q9HCC8; -.
DR   PhosphoSitePlus; Q9HCC8; -.
DR   BioMuta; GDPD2; -.
DR   DMDM; 74752794; -.
DR   jPOST; Q9HCC8; -.
DR   MassIVE; Q9HCC8; -.
DR   PaxDb; 9606-ENSP00000414019; -.
DR   PeptideAtlas; Q9HCC8; -.
DR   ProteomicsDB; 81668; -. [Q9HCC8-1]
DR   ProteomicsDB; 81669; -. [Q9HCC8-2]
DR   ProteomicsDB; 81670; -. [Q9HCC8-3]
DR   Antibodypedia; 27419; 130 antibodies from 20 providers.
DR   DNASU; 54857; -.
DR   Ensembl; ENST00000374382.4; ENSP00000363503.3; ENSG00000130055.14. [Q9HCC8-1]
DR   Ensembl; ENST00000453994.6; ENSP00000414019.2; ENSG00000130055.14. [Q9HCC8-3]
DR   Ensembl; ENST00000536730.5; ENSP00000445982.1; ENSG00000130055.14. [Q9HCC8-2]
DR   Ensembl; ENST00000538649.5; ENSP00000444601.1; ENSG00000130055.14. [Q9HCC8-2]
DR   GeneID; 54857; -.
DR   KEGG; hsa:54857; -.
DR   MANE-Select; ENST00000374382.4; ENSP00000363503.3; NM_017711.4; NP_060181.2.
DR   UCSC; uc004dyh.4; human. [Q9HCC8-1]
DR   AGR; HGNC:25974; -.
DR   CTD; 54857; -.
DR   GeneCards; GDPD2; -.
DR   HGNC; HGNC:25974; GDPD2.
DR   HPA; ENSG00000130055; Group enriched (choroid plexus, intestine, lymphoid tissue, skin).
DR   MIM; 300940; gene.
DR   neXtProt; NX_Q9HCC8; -.
DR   OpenTargets; ENSG00000130055; -.
DR   PharmGKB; PA134907263; -.
DR   VEuPathDB; HostDB:ENSG00000130055; -.
DR   eggNOG; KOG2258; Eukaryota.
DR   GeneTree; ENSGT00940000159625; -.
DR   HOGENOM; CLU_024259_1_0_1; -.
DR   InParanoid; Q9HCC8; -.
DR   OMA; DPPGCCS; -.
DR   OrthoDB; 1058301at2759; -.
DR   PAN-GO; Q9HCC8; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9HCC8; -.
DR   TreeFam; TF313692; -.
DR   BRENDA; 3.1.4.46; 2681.
DR   BRENDA; 4.6.1.14; 2681.
DR   PathwayCommons; Q9HCC8; -.
DR   SignaLink; Q9HCC8; -.
DR   BioGRID-ORCS; 54857; 20 hits in 773 CRISPR screens.
DR   ChiTaRS; GDPD2; human.
DR   GenomeRNAi; 54857; -.
DR   Pharos; Q9HCC8; Tbio.
DR   PRO; PR:Q9HCC8; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q9HCC8; protein.
DR   Bgee; ENSG00000130055; Expressed in spleen and 128 other cell types or tissues.
DR   GO; GO:0005884; C:actin filament; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0030027; C:lamellipodium; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0008889; F:glycerophosphodiester phosphodiesterase activity; IBA:GO_Central.
DR   GO; GO:0047394; F:glycerophosphoinositol inositolphosphodiesterase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007015; P:actin filament organization; IEA:Ensembl.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:InterPro.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl.
DR   CDD; cd08609; GDPD_GDE3; 1.
DR   Gene3D; 3.20.20.190; Phosphatidylinositol (PI) phosphodiesterase; 1.
DR   InterPro; IPR030395; GP_PDE_dom.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   PANTHER; PTHR23344:SF1; GLYCEROPHOSPHOINOSITOL INOSITOLPHOSPHODIESTERASE GDPD2; 1.
DR   PANTHER; PTHR23344; GLYCEROPHOSPHORYL DIESTER PHOSPHODIESTERASE; 1.
DR   Pfam; PF03009; GDPD; 1.
DR   Pfam; PF13653; GDPD_2; 1.
DR   SUPFAM; SSF51695; PLC-like phosphodiesterases; 1.
DR   PROSITE; PS51704; GP_PDE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cytoplasm; Cytoskeleton; Glycoprotein;
KW   Hydrolase; Membrane; Metal-binding; Proteomics identification;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..539
FT                   /note="Glycerophosphoinositol inositolphosphodiesterase
FT                   GDPD2"
FT                   /id="PRO_0000251934"
FT   TOPO_DOM        1..38
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        39..59
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        60..85
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        86..106
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        107..121
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        122..142
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        143..154
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        155..175
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        176..188
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        189..209
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        210..490
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        491..511
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        512..539
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          224..479
FT                   /note="GP-PDE"
FT   BINDING         256
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000255"
FT   BINDING         258
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000255"
FT   BINDING         271
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        442
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..79
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042622"
FT   VAR_SEQ         436
FT                   /note="K -> KDRFLLPAQAGLKLLASSNLPASASQSAGITGLSHCPPQPPGYKHEL
FT                   SHLAM (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042623"
FT   CONFLICT        418
FT                   /note="E -> G (in Ref. 3; BAA91014)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   539 AA;  61729 MW;  8271C3A74766D540 CRC64;
     MAESPGCCSV WARCLHCLYS CHWRKCPRER MQTSKCDCIW FGLLFLTFLL SLSWLYIGLV
     LLNDLHNFNE FLFRRWGHWM DWSLAFLLVI SLLVTYASLL LVLALLLRLC RQPLHLHSLH
     KVLLLLIMLL VAAGLVGLDI QWQQEWHSLR VSLQATAPFL HIGAAAGIAL LAWPVADTFY
     RIHRRGPKIL LLLLFFGVVL VIYLAPLCIS SPCIMEPRDL PPKPGLVGHR GAPMLAPENT
     LMSLRKTAEC GATVFETDVM VSSDGVPFLM HDEHLSRTTN VASVFPTRIT AHSSDFSWTE
     LKRLNAGSWF LERRPFWGAK PLAGPDQKEA ESQTVPALEE LLEEAAALNL SIMFDLRRPP
     QNHTYYDTFV IQTLETVLNA RVPQAMVFWL PDEDRANVQR RAPGMRQIYG RQGGNRTERP
     QFLNLPYQDL PLLDIKALHK DNVSVNLFVV NKPWLFSLLW CAGVDSVTTN DCQLLQQMRY
     PIWLITPQTY LIIWVITNCV STMLLLWTFL LQRRFVKKRG KTGLETAVLL TRINNFMME
//
